10-Q - Jazz Pharmaceuticals | Modeledge

Jazz Pharmaceuticals

Filing type: 10-Q
Filing date: Aug 2, 2026
Updated: Aug 3, 2026 · 2:08 PM

Filing

Exhibits

EX-10.1NON-EMPLOYEE DIRECTOR COMPENSATION POLICY EX-31.1CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)EX-31.2CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)EX-32.1CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350